Fernandez M, Hickman M E, Baker C J
Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.
Antimicrob Agents Chemother. 1998 Jun;42(6):1517-9. doi: 10.1128/AAC.42.6.1517.
In vitro testing of 229 group B streptococcal isolates from a variety of patients with invasive infections indicated uniform penicillin G susceptibility. However, 17 (7.4%) isolates were resistant to erythromycin and 8 (3.4%) were resistant to clindamycin. These results support the continued use of penicillin G as the drug of choice for the treatment and prevention of group B streptococcal disease.
对来自各类侵袭性感染患者的229株B族链球菌分离株进行的体外试验表明,这些菌株对青霉素G均敏感。然而,有17株(7.4%)分离株对红霉素耐药,8株(3.4%)对克林霉素耐药。这些结果支持继续将青霉素G作为治疗和预防B族链球菌病的首选药物。